Evaluation of database-derived pathway development for enabling biomarker discovery for hepatotoxicity.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Biomarkers in Medicine

• Publication date

  2014-02-12

• Fields of study

  Biology, Medicine, Computer Science

• Identifiers
  DOI 10.2217/bmm.13.154PMID 24521014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Idiosyncratic drug-induced liver injury: an update on the 2007 overview

  2014cited by this paper
• A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity.

  2013cited by this paper
• Baseline and genotoxic compound induced gene expression profiles in HepG2 and HepaRG compared to primary human hepatocytes.

  2013cited by this paper
• Drug-induced liver injury in obesity.

  2013cited by this paper
• Transcriptomic responses generated by hepatocarcinogens in a battery of liver-based in vitro models.

  2013cited by this paper
• Lack of liver injury in Wistar rats treated with the combination of isoniazid and rifampicin

  2013cited by this paper
• Global Gene Expression Profiling Reveals SPINK1 as a Potential Hepatocellular Carcinoma Marker

  2013cited by this paper
• Evaluation of the metabolism and hepatotoxicity of xenobiotics utilizing precision-cut slices

  2013cited by this paper
• Surveillance for hepatocellular carcinoma in chronic liver disease: evidence and controversies.

  2013cited by this paper
• Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.

  2013cited by this paper
• MalaCards: an integrated compendium for diseases and their annotation

  2013cited by this paper
• Prediction of dose-hepatotoxic response in humans based on toxicokinetic/toxicodynamic modeling with or without in vivo data: a case study with acetaminophen.

  2013cited by this paper
• Sandwich-cultured hepatocytes: utility for in vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity

  2013cited by this paper
• Multiplex transcriptional analysis of paraffin-embedded liver needle biopsy from patients with liver fibrosis

  2012cited by this paper
• In silico models for drug-induced liver injury – current status

  2012cited by this paper
• Liver Regeneration Signature in Hepatitis B Virus (HBV)-Associated Acute Liver Failure Identified by Gene Expression Profiling

  2012cited by this paper
• Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins

  2012cited by this paper
• Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis

  2012cited by this paper
• The Comparative Toxicogenomics Database: update 2013

  2012cited by this paper
• Proteomics in the search for mechanisms and biomarkers of drug-induced hepatotoxicity.

  2012cited by this paper
• The use of genomics in model in vitro systems.

  2012cited by this paper
• Gene Expression Profiling Unravels Cancer-Related Hepatic Molecular Signatures in Steatohepatitis but Not in Steatosis

  2012cited by this paper
• Early transcriptional programming links progression to hepatitis C virus–induced severe liver disease in transplant patients

  2012cited by this paper
• Direct Oxidation and Covalent Binding of Isoniazid to Rodent Liver and Human Hepatic Microsomes: Humans Are More Like Mice than Rats

  2012cited by this paper
• Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.

  2012cited by this paper
• Comparisons between in vitro whole cell imaging and in vivo zebrafish-based approaches for identifying potential human hepatotoxicants earlier in pharmaceutical development

  2012cited by this paper
• Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins

  2012cited by this paper
• Similarities and Differences in the Expression of Drug-Metabolizing Enzymes between Human Hepatic Cell Lines and Primary Human Hepatocytes

  2011cited by this paper
• Case Definition and Phenotype Standardization in Drug‐Induced Liver Injury

  2011cited by this paper
• Alcoholic liver disease: pathogenesis and new therapeutic targets.

  2011cited by this paper
• WikiPathways: building research communities on biological pathways

  2011cited by this paper
• Dysregulation of IFN System Can Lead to Poor Response to Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis C

  2011cited by this paper
• FDA-approved drug labeling for the study of drug-induced liver injury.

  2011cited by this paper
• Analysis of Global and Absorption, Distribution, Metabolism, and Elimination Gene Expression in the Progressive Stages of Human Nonalcoholic Fatty Liver Disease

  2011cited by this paper
• Review article: drug‐induced liver injury – its pathophysiology and evolving diagnostic tools

  2011cited by this paper
• Protease profiling of liver fibrosis reveals the ADAM metallopeptidase with thrombospondin type 1 motif, 1 as a central activator of transforming growth factor beta

  2011cited by this paper
• Upregulation of Hemoglobin Expression by Oxidative Stress in Hepatocytes and Its Implication in Nonalcoholic Steatohepatitis

  2011cited by this paper
• EU framework 6 project: predictive toxicology (PredTox)--overview and outcome.

  2011cited by this paper
• In-silico human genomics with GeneCards

  2011cited by this paper
• Mechanisms of acetaminophen-induced liver necrosis.

  2010cited by this paper
• A Comparison of Whole Genome Gene Expression Profiles of HepaRG Cells and HepG2 Cells to Primary Human Hepatocytes and Human Liver Tissues

  2010cited by this paper
• Library of molecular associations: curating the complex molecular basis of liver diseases

  2010cited by this paper
• Drug-induced liver injury: a clinical update

  2010cited by this paper
• System-dependent outcomes during the evaluation of drug candidates as inhibitors of cytochrome P450 (CYP) and uridine diphosphate glucuronosyltransferase (UGT) enzymes: human hepatocytes versus liver microsomes versus recombinant enzymes.

  2010cited by this paper
• The Japanese toxicogenomics project: application of toxicogenomics.

  2010cited by this paper
• Liver injury caused by drugs: an update.

  2010cited by this paper
• Developing and Characterizing a Mouse Model of Hepatotoxicity Using Oral Pyrrolizidine Alkaloid (Monocrotaline) Administration, with Potentiation of the Liver Injury by Co-administration of LPS

  2010cited by this paper
• Cytoscape 2.8: new features for data integration and network visualization

  2010cited by this paper
• Current Concepts of Mechanisms in Drug-Induced Hepatotoxicity

  2009cited by this paper
• Drug-induced liver injury: is it somehow foreseeable?

  2009cited by this paper
• MedScape

  2009cited by this paper
• Polymorphism of human cytochrome P450 enzymes and its clinical impact

  2009cited by this paper
• Epidemiology of idiosyncratic drug-induced liver injury.

  2009cited by this paper
• Integrating and annotating the interactome using the MiMI plugin for cytoscape

  2009cited by this paper
• Novel serum markers of fibrosis progression for the follow-up of hepatitis C virus-infected patients.

  2009cited by this paper
• Presenting and exploring biological pathways with PathVisio

  2008cited by this paper
• Michigan molecular interactions r2: from interacting proteins to pathways

  2008cited by this paper
• An update on metabolism studies using human hepatocytes in primary culture

  2008cited by this paper
• An update on metabolism studies using human hepatocytes in primary culture.

  2008cited by this paper
• Gene Expression Omnibus ( GEO ) : Microarray data storage , submission , retrieval , and analysis

  2008cited by this paper
• Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists.

  2007cited by this paper
• Review article: drug hepatotoxicity

  2007cited by this paper
• Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma

  2007cited by this paper
• Causality assessment of drug-induced hepatotoxicity: promises and pitfalls.

  2007cited by this paper
• GenMAPP 2: new features and resources for pathway analysis

  2007cited by this paper
• Acute liver failure: Summary of a workshop

  2007cited by this paper
• Human hepatocytes: isolation, cryopreservation and applications in drug development.

  2007cited by this paper
• Michigan Molecular Interactions (MiMI): putting the jigsaw puzzle together

  2006cited by this paper
• Acetaminophen‐induced acute liver failure: Results of a United States multicenter, prospective study

  2006cited by this paper
• Primary Sclerosing Cholangitis and Cholangiocarcinoma

  2006cited by this paper
• Drug‐induced liver injury: Hy's rule revisited

  2006cited by this paper
• Acetaminophen‐induced acute liver failure: Results of a United States multicenter, prospective study

  2005cited by this paper
• New Technologies and Screening Strategies for Hepatotoxicity: Use of In Vitro Models

  2005cited by this paper
• The Burden of Acute Nonfulminant Drug-induced Hepatitis in a United States Tertiary Referral Center

  2005cited by this paper
• Role of animal models in the study of drug-induced hypersensitivity reactions

  2005cited by this paper
• ArrayExpress—a public repository for microarray gene expression data at the EBI

  2004cited by this paper
• First dose of potential new medicines to humans: how animals help

  2004cited by this paper
• Human hepatocytes in primary culture: the choice to investigate drug metabolism in man.

  2004cited by this paper
• Causality assessment in drug-induced hepatotoxicity

  2004cited by this paper
• In silico prediction of drug safety: despite progress there is abundant room for improvement.

  2004cited by this paper
• Liver transplantation for acute liver failure from drug induced liver injury in the United States

  2004cited by this paper
• The Comparative Toxicogenomics Database (CTD).

  2003cited by this paper
• ArrayExpress - a public repository for microarray gene expression data at the EBI

  2003cited by this paper
• Drug-induced hepatotoxicity.

  2003cited by this paper
• An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons.

  2003cited by this paper
• Cytoscape: a software environment for integrated models of biomolecular interaction networks.

  2003cited by this paper
• Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties.

  2003cited by this paper
• Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

  2002cited by this paper
• Genetic basis of drug metabolism.

  2002cited by this paper
• Hepatotoxicity of Commonly Used Drugs: Nonsteroidal Anti-Inflammatory Drugs, Antihypertensives, Antidiabetic Agents, Anticonvulsants, Lipid-Lowering Agents, Psychotropic Drugs

  2002cited by this paper
• Timing of new black box warnings and withdrawals for prescription medications.

  2002cited by this paper
• Incidence of drug‐induced hepatic injuries: A French population‐based study

  2002cited by this paper
• Drug‐induced liver injury: Mechanisms and test systems

  2001cited by this paper
• Concordance of the toxicity of pharmaceuticals in humans and in animals.

  2000cited by this paper
• Species differences in hepatocyte induction of CYP1A1 and CYP1A2 by omeprazole

  1999cited by this paper
• Liver cell models in in vitro toxicology.

  1998cited by this paper
• The predictivity of the toxicity of pharmaceuticals in humans from animal data--an interim assessment.

  1998cited by this paper
• Drug-induced hepatotoxicity.

  1995cited by this paper

• Hepatotoxic mechanism of cantharidin: insights and strategies for therapeutic intervention

  2023cites this paper
• Integration of the Connectivity Map and Pathway Analysis to Predict Plant Extract’s Medicinal Properties—The Study Case of Sarcopoterium spinosum L.

  2022cites this paper
• The progression of chronicity and autoimmune hepatitis in recurrent drug-induced liver injury.

  2022cites this paper
• Hepatic Organoid-Based High-Content Imaging Boosts Evaluation of Stereoisomerism-Dependent Hepatotoxicity of Stilbenes in Herbal Medicines

  2022cites this paper
• Effects on mammalian cell transcriptome reveal a plant extract's medicinal properties: Potential anti-COVID-19 and anti-cancer properties of Sarcopoterium spinosum

  2022cites this paper
• Omics resources

  2020cites this paper
• Herb-Induced Liver Injury: Phylogenetic Relationship, Structure-Toxicity Relationship, and Herb-Ingredient Network Analysis

  2019cites this paper
• A Computational Toxicology Approach to Screen the Hepatotoxic Ingredients in Traditional Chinese Medicines: Polygonum multiflorum Thunb as a Case Study

  2019cites this paper
• Chinese Herbal Medicine Hepatotoxicity: The Evaluation and Recognization Based on Large-scale Evidence Database

  2018cites this paper
• Analysis of Time-Series Gene Expression Data to Explore Mechanisms of Chemical-Induced Hepatic Steatosis Toxicity

  2018cites this paper
• Validation of gene expression profiles from cholestatic hepatotoxicants in vitro against human in vivo cholestasis.

  2017cites this paper
• In vitro and in vivo experimental hepatotoxic models in liver research: applications to the assessment of potential hepatoprotective drugs.

  2016cites this paper
• diXa data warehouse: Exploring data from toxicogenomics studies

  2016cites this paper
• Liver Fatty Acid Binding Protein And Hemojuvelin - Potential Biomarkers For Liver Function in Rat Model

  2015cites this paper
• Development of novel tools for the in vitro investigation of drug-induced liver injury

  2015cites this paper
• Characterization of Conserved Toxicogenomic Responses in Chemically Exposed Hepatocytes across Species and Platforms

  2015cites this paper
• diXa: a data infrastructure for chemical safety assessment

  2014cites this paper
• Emerging efforts for discovering new biomarkers of liver disease and hepatotoxicity.

  2014cites this paper